The progress in understanding and treatment of diabetic retinopathy

Agardh, 2000, Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats, Curr. Eye Res., 21, 543, 10.1076/0271-3683(200007)2111-ZFT543 Aiello, 2008, Targeting intraocular neovascularization and edema–one drop at a time, N. Engl. J. Med., 359, 967, 10.1056/NEJMcibr0804551 Aiello, 1994, Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders, N. Engl. J. Med., 331, 1480, 10.1056/NEJM199412013312203 Aiello, 2006, Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients, Investig. Ophthalmol. Vis.Sci., 47, 86, 10.1167/iovs.05-0757 Aiello, 2010, Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema, Ophthalmology, 117, 946, 10.1016/j.ophtha.2009.10.002 Alibrahim, 2006, Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes, Ophthalmology, 113, 1499, 10.1016/j.ophtha.2006.05.009 Alikhani, 2010, FOXO1 plays an essential role in apoptosis of retinal pericytes, Mol. Vis., 16, 408 Alkhalaf, 2012, Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy, PLoS One, 7, e40427, 10.1371/journal.pone.0040427 Amemiya, 2001, Retinal vascular changes and systemic diseases: corrosion cast demonstration, Ital. J. Anat. Embryol., 106, 237 Anderson, 1964, Retinal oxygen utilization measured by hyperbaric blackout, Arch. Ophthalmol., 72, 792, 10.1001/archopht.1964.00970020794009 Anderson, 1993, Induction of alloxan/streptozotocin diabetes in dogs: a revised experimental technique, Lab. Anim., 27, 281, 10.1258/002367793780745426 Antonetti, 2012, Diabetic retinopathy, N. Engl. J. Med., 366, 1227, 10.1056/NEJMra1005073 Araszkiewicz, 2012, Neurodegeneration of the retina in type 1 diabetic patients, Pol. Arch. Med. Wewnetrznej, 122, 464 Arrigg, 1998, The role of vitrectomy for diabetic retinopathy, J. Am. Optom. Assoc., 69, 733 Aspelund, 2011, Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy, Diabetologia, 54, 2525, 10.1007/s00125-011-2257-7 Attwell, 2010, Glial and neuronal control of brain blood flow, Nature, 468, 232, 10.1038/nature09613 Awata, 2014, A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA, PLoS One, 9, e111715, 10.1371/journal.pone.0111715 Azad, 2014, Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT), Diabetes Care, 37, 501, 10.2337/dc13-1193 Ballantyne, 1943, The pathology of diabetic retinopathy, Trans. Ophthalmol. Soc. U. K., 63, 95 Barber, 2005, The Ins2Akita mouse as a model of early retinal complications in diabetes, Investig. Ophthalmol. Vis. Sci., 46, 2210, 10.1167/iovs.04-1340 Barber, 1998, Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin, J.Clin. Investig., 102, 783, 10.1172/JCI2425 Barile, 2005, The RAGE axis in early diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 46, 2916, 10.1167/iovs.04-1409 Baskin, 1999, Renal vascular abnormalities in Bardet-Biedl syndrome, Pediatr. Nephrol., 13, 787, 10.1007/s004670050701 Bearse, 2006, A multifocal electroretinogram model predicting the development of diabetic retinopathy, Prog. Retin. Eye Res., 25, 425, 10.1016/j.preteyeres.2006.07.001 Beasley, 2014, Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema, BioMed Res. Int., 2014, 417986, 10.1155/2014/417986 Bek, 1997, Glial cell involvement in vascular occlusion of diabetic retinopathy, Acta Ophthalmol. Scand., 75, 239, 10.1111/j.1600-0420.1997.tb00764.x Bek, 1997, Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy, Acta Ophthalmol. Scand., 75, 388, 10.1111/j.1600-0420.1997.tb00395.x Bek, 1999, Venous loops and reduplications in diabetic retinopathy. Prevalence, distribution, and pattern of development, Acta Ophthalmol. Scand., 77, 130, 10.1034/j.1600-0420.1999.770202.x Bek, 2002, A clinicopathological study of venous loops and reduplications in diabetic retinopathy, Acta Ophthalmol. Scand., 80, 69, 10.1034/j.1600-0420.2002.800114.x Bek, 2013, Regional morphology and pathophysiology of retinal vascular disease, Prog. Retin. Eye Res., 36, 247, 10.1016/j.preteyeres.2013.07.002 Bek, 2013, Relaxation of porcine retinal arterioles exposed to hypercholesterolemia in vivo is modified by hepatic LDL-receptor deficiency and diabetes mellitus, Exp. Eye Res., 115, 79, 10.1016/j.exer.2013.06.013 Bek, 2013, Spontaneous high frequency diameter oscillations of larger retinal arterioles are reduced in type 2 diabetes mellitus, Investig. Ophthalmol. Vis. Sci., 54, 636, 10.1167/iovs.12-11182 Beltramo, 2009, Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes, Diabetes Metab. Res. Rev., 25, 647, 10.1002/dmrr.1008 Beltramo, 2002, Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations, Diabetologia, 45, 416, 10.1007/s00125-001-0761-x Benjamin, 1998, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125, 1591, 10.1242/dev.125.9.1591 Berkowitz, 1999, Subnormal retinal oxygenation response precedes diabetic-like retinopathy, Investig. Ophthalmol. Vis. Sci., 40, 2100 Berner, 2012, Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology, Diabetologia, 55, 845, 10.1007/s00125-011-2393-0 Berrone, 2006, Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose, J. Biol. Chem., 281, 9307, 10.1074/jbc.M600418200 Bhatwadekar, 2008, A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats, Br. J. Ophthalmol., 92, 545, 10.1136/bjo.2007.127910 Bhatwadekar, 2009, Retinal endothelial cell apoptosis stimulates recruitment of endothelial progenitor cells, Investig. Ophthalmol. Vis. Sci., 50, 4967, 10.1167/iovs.09-3616 Bhatwadekar, 2008, Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 49, 1232, 10.1167/iovs.07-1015 Biedermann, 2004, GABA(A) receptors in Muller glial cells of the human retina, Glia, 46, 302, 10.1002/glia.20004 Bill, 1975, Blood circulation and fluid dynamics in the eye, Physiol. Rev., 55, 383, 10.1152/physrev.1975.55.3.383 Bogdanov, 2014, The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration, PLoS One, 9, e97302, 10.1371/journal.pone.0097302 Bonne, 1998, Free radicals in retinal ischemia, Gen. Pharmacol., 30, 275, 10.1016/S0306-3623(97)00357-1 Bouma, 2004, Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin, Diabetes, 53, 1979, 10.2337/diabetes.53.8.1979 Braun, 2009, Erythrocyte flow in choriocapillaris of normal and diabetic rats, Microvasc. Res., 77, 247, 10.1016/j.mvr.2009.02.003 Bresnick, 1977, Clinicopathologic correlations in diabetic retinopathy. II. Clinical and histologic appearances of retinal capillary microaneurysms, Arch. Ophthalmol., 95, 1215, 10.1001/archopht.1977.04450070113010 Bringmann, 2012, Muller glial cells in retinal disease, Ophthalmologica, 227, 1, 10.1159/000328979 Broe, 2014, Retinal vessel calibers predict long-term microvascular complications in type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987), Diabetes, 63, 3906, 10.2337/db14-0227 Brownlee, 2001, Biochemistry and molecular cell biology of diabetic complications, Nature, 414, 813, 10.1038/414813a Buchi, 1996, Retinopathy in diabetic hypertensive monkeys: a pathologic study, Graefes Arch. Clin. Exp. Ophthalmol., 234, 388, 10.1007/BF00190716 Budzynski, 2005, Intraretinal pH in diabetic cats, Curr. Eye Res., 30, 229, 10.1080/02713680590934067 Bursell, 1996, Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 37, 886 Buttery, 1991, How thick should a retina be? A comparative study of mammalian species with and without intraretinal vasculature, Vis. Res., 31, 169, 10.1016/0042-6989(91)90110-Q Calcutt, 2009, Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials, Nat. Rev. Drug Discov., 8, 417, 10.1038/nrd2476 Cao, 1998, Choriocapillaris degeneration and related pathologic changes in human diabetic eyes, Arch. Ophthalmol., 116, 589, 10.1001/archopht.116.5.589 Carmeliet, 1998, Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, Nature, 394, 485, 10.1038/28867 Carrasco, 2008, Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation, Mol. Vis., 14, 1496 Carrasco, 2007, Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration, Diabetes Care, 30, 2902, 10.2337/dc07-0332 Catalani, 2007, Changes in neuronal response to ischemia in retinas with genetic alterations of somatostatin receptor expression, Eur. J. Neurosci., 25, 1447, 10.1111/j.1460-9568.2007.05419.x Chakravarthy, 2013, Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial, Lancet, 382, 1258, 10.1016/S0140-6736(13)61501-9 Chang, 2014, High glucose activates ChREBP-mediated HIF-1alpha and VEGF expression in human RPE cells under normoxia, Adv. Exp. Med. Biol., 801, 609, 10.1007/978-1-4614-3209-8_77 Cherian, 2009, Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats, Investig. Ophthalmol. Vis. Sci., 50, 943, 10.1167/iovs.08-2377 Cheung, 2008, Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes, Diabetes Care, 31, 1842, 10.2337/dc08-0189 Chew, 2014, The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, Ophthalmology, 121, 2443, 10.1016/j.ophtha.2014.07.019 Chew, 1996, Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22, Arch. Ophthalmol., 114, 1079, 10.1001/archopht.1996.01100140281004 Chibber, 2007, Leukocytes in diabetic retinopathy, Curr. Diabetes Rev., 3, 3, 10.2174/157339907779802139 Kearney, 2008, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet, 371, 117, 10.1016/S0140-6736(08)60104-X Chowdhury, 2002, The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?, Eye, 16, 689, 10.1038/sj.eye.6700205 Ciulla, 2002, Ocular perfusion abnormalities in diabetes, Acta Ophthalmol. Scand., 80, 468, 10.1034/j.1600-0420.2002.800503.x Clermont, 1997, Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy, Am. J. Ophthalmol., 124, 433, 10.1016/S0002-9394(14)70860-8 Cogan, 1961, Retinal vascular patterns. IV. Diabetic retinopathy, Arch. Ophthalmol., 66, 366, 10.1001/archopht.1961.00960010368014 Collins, 2015, A new initiative on precision medicine, N. Engl. J. Med., 372, 793, 10.1056/NEJMp1500523 Connor, 2009, Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis, Nat. Protoc., 4, 1565, 10.1038/nprot.2009.187 Cooper, 2010, Epigenetics: mechanisms and implications for diabetic complications, Circ. Res., 107, 1403, 10.1161/CIRCRESAHA.110.223552 Costagliola, 2013, TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy, Mediat. Inflamm., 2013, 629529, 10.1155/2013/629529 Crosby-Nwaobi, 2012, Retinal vascular calibre, geometry and progression of diabetic retinopathy in type 2 diabetes mellitus, Ophthalmologica, 228, 84, 10.1159/000337252 Cunha-Vaz, 2011, Blood-retinal barrier, Eur. J. Ophthalmol., 21, S3, 10.5301/EJO.2010.6049 Cunha-Vaz, 1975, Early breakdown of the blood-retinal barrier in diabetes, Br. J. Ophthalmol., 59, 649, 10.1136/bjo.59.11.649 Cunha-Vaz, 2014, Phenotypes and biomarkers of diabetic retinopathy, Prog. Retin. Eye Res., 41, 90, 10.1016/j.preteyeres.2014.03.003 Cunha-Vaz, 1976, The blood-retinal barriers, Doc. Ophthalmol., 41, 287, 10.1007/BF00146764 Cunha-Vaz, 1981, Vitreous fluorophotometry studies in diabetes, Dev. Ophthalmol., 2, 214, 10.1159/000395326 Curtis, 2012, 365 Curtis, 2009, Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?, Eye (Lon., Engl.), 23, 1496, 10.1038/eye.2009.108 Curtis, 2011, Muller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products, Diabetologia, 54, 690, 10.1007/s00125-010-1971-x D'Amore, 2007, Vascular endothelial cell growth factor-a: not just for endothelial cells anymore, Am. J. Pathol., 171, 14, 10.2353/ajpath.2007.070385 D'Cruz, 2012, Post-translational processing of synaptophysin in the rat retina is disrupted by diabetes, PLoS One, 7, e44711, 10.1371/journal.pone.0044711 DCCT, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 de Gooyer, 2006, Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration, Investig. Ophthalmol. Vis. Sci., 47, 5561, 10.1167/iovs.06-0647 De Vriese, 2000, Endothelial dysfunction in diabetes, Br. J. Pharmacol., 130, 963, 10.1038/sj.bjp.0703393 Dean, 1997, Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects, Br. J. Ophthalmol., 81, 27, 10.1136/bjo.81.1.27 Deckert, 1978, Importance of outpatient supervision in the prognosis of juvenile diabetes mellitus: a cost/benefit analysis, Diabetes Care, 1, 281, 10.2337/diacare.1.5.281 Deckert, 1978, Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications, Diabetologia, 14, 363, 10.1007/BF01228130 Delaey, 2000, A retinal-derived relaxing factor mediates the hypoxic vasodilation of retinal arteries, Investig. Ophthalmol. Vis. Sci., 41, 3555 Derakhshan, 2012, Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1beta gene in the Iranian population, Inflammation, 35, 900, 10.1007/s10753-011-9391-8 Devaraj, 2011, Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes, Cytokine, 55, 441, 10.1016/j.cyto.2011.03.023 Lachin, 2015, Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC, Diabetes, 64, 631, 10.2337/db14-0930 Beck, 2009, Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema, Arch. Ophthalmol., 127, 245, 10.1001/archophthalmol.2008.610 Elman, 2010, Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema, Ophthalmology, 117, 10.1016/j.ophtha.2010.02.031 Elman, 2012, Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results, Ophthalmology, 119, 2312, 10.1016/j.ophtha.2012.08.022 Diffley, 2009, Apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes is independent of activation of MAPK signaling pathways, Mol. Vis., 15, 135 Ding, 2014, Peroxisome proliferator-activated receptor alpha protects capillary pericytes in the retina, Am. J. Pathol., 184, 2709, 10.1016/j.ajpath.2014.06.021 Do, 2011, The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema, Ophthalmology, 118, 1819, 10.1016/j.ophtha.2011.02.018 Do, 2015, Blood pressure control for diabetic retinopathy, Cochrane Database Syst. Rev., 1, CD006127 Donato, 2001, S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles, Int. J. Biochem. Cell Biol., 33, 637, 10.1016/S1357-2725(01)00046-2 Du, 2013, Effects of modified LDL and HDL on retinal pigment epithelial cells: a role in diabetic retinopathy?, Diabetologia, 56, 2318, 10.1007/s00125-013-2986-x Dunmire, 2013, MicroRNA in aqueous humor from patients with cataract, Exp. Eye Res., 108, 68, 10.1016/j.exer.2012.10.016 Edelman, 2005, Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown, Exp. Eye Res., 80, 249, 10.1016/j.exer.2004.09.013 El-Osta, 2008, Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia, J. Exp. Med., 205, 2409, 10.1084/jem.20081188 Elley, 2010, Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the New Zealand diabetes cohort study, Diabetes Care, 33, 1347, 10.2337/dc09-1444 Elman, 2015, Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results, Ophthalmology, 122, 375, 10.1016/j.ophtha.2014.08.047 Engerman, 1987, Progression of incipient diabetic retinopathy during good glycemic control, Diabetes, 36, 808, 10.2337/diab.36.7.808 Engerman, 1990, Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia, Metabolism, 39, 638, 10.1016/0026-0495(90)90032-8 Erickson, 2007, Vascular permeability in ocular disease and the role of tight junctions, Angiogenesis, 10, 103, 10.1007/s10456-007-9067-z Esmaeelpour, 2012, Choroidal thinning in diabetes type 1 detected by 3-dimensional 1060 nm optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 53, 6803, 10.1167/iovs.12-10314 ETDRS, 1991, Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group, Ophthalmology, 98, 766 Feenstra, 2013, Modes of retinal cell death in diabetic retinopathy, J. Clin. Exp. Ophthalmol., 4, 298 Feng, 2012, Crosstalk in the retinal neurovascular unit – lessons for the diabetic retina, Exp. Clin. Endocrinol. Diabetes, 120, 199, 10.1055/s-0032-1304571 Feng, 2009, Vasoregression linked to neuronal damage in the rat with defect of polycystin-2, PLoS One, 4, e7328, 10.1371/journal.pone.0007328 Fitzgerald, 2005, Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes, Clin. Exp. Pharmacol. Physiol., 32, 482, 10.1111/j.1440-1681.2005.04216.x Fletcher, 2010, The renin-angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature, Prog. Retin. Eye Res., 29, 284, 10.1016/j.preteyeres.2010.03.003 Ford, 2013, Current treatments in diabetic macular oedema: systematic review and meta-analysis, BMJ Open, 3, 10.1136/bmjopen-2012-002269 Fort, 2011, Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance, PLoS One, 6, e26498, 10.1371/journal.pone.0026498 Fraser, 2012, The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial, Diabetes Care, 35, 1095, 10.2337/dc11-1895 Fryczkowski, 1989, Diabetic choroidal and iris vasculature scanning electron microscopy findings, Int. Ophthalmol., 13, 269, 10.1007/BF02280087 Fu, 2012, Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy, Diabetologia, 55, 3128, 10.1007/s00125-012-2692-0 Fu, 2014, Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes, J. Lipid Res., 55, 860, 10.1194/jlr.M045401 Funatsu, 2006, Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema, Ophthalmology, 113, 294, 10.1016/j.ophtha.2005.10.030 Garcia-Ramirez, 2009, Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy, Diabetologia, 52, 2633, 10.1007/s00125-009-1548-8 Garcia-Ramirez, 2011, Measuring permeability in human retinal epithelial cells (ARPE-19): implications for the study of diabetic retinopathy, Methods Mol. Biol., 763, 179, 10.1007/978-1-61779-191-8_12 Gardiner, 2005, Modulation of retinal angiogenesis in oxygen-induced retinopathy by inhibition of inflammatory cytokines, Am. J. Pathology, 166, 637, 10.1016/S0002-9440(10)62284-5 Gardiner, 2003, Prevention of retinal capillary basement membrane thickening in diabetic dogs by a non-steroidal anti-inflammatory drug, Diabetologia, 46, 1269, 10.1007/s00125-003-1147-z Gardiner, 2003, Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes, J. Pathol., 201, 328, 10.1002/path.1429 Gardiner, 2007, Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis, Microcirculation, 14, 25, 10.1080/10739680601072123 Gardiner, 1994, Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs, Br. J. Ophthalmol., 78, 54, 10.1136/bjo.78.1.54 Garner, 1993, Histopathology of diabetic retinopathy in man, Eye, 7, 250, 10.1038/eye.1993.58 Gebarowska, 2002, Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularization, Am. J. Pathol., 160, 307, 10.1016/S0002-9440(10)64374-X Geraldes, 2009, Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy, Nat. Med., 15, 1298, 10.1038/nm.2052 Giacco, 2010, Oxidative stress and diabetic complications, Circ. Res., 107, 1058, 10.1161/CIRCRESAHA.110.223545 Gidday, 1993, Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet, Investig. Ophthalmol. Vis. Sci., 34, 2713 Giusti, 2001, Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study, Int. Ophthalmol., 24, 79, 10.1023/A:1016354517304 Gorudko, 2012, Functional activity of neutrophils in diabetes mellitus and coronary heart disease: role of myeloperoxidase in the development of oxidative stress, Bull. Exp. Biol. Med., 154, 23, 10.1007/s10517-012-1865-7 Gross, 2013, Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes, Mol. Vis., 19, 54 Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N. Engl. J. Med., 358, 2560, 10.1056/NEJMoa0802987 Aiello, 2015, Intensive diabetes therapy and ocular surgery in type 1 diabetes, N. Engl. J. Med., 372, 1722, 10.1056/NEJMoa1409463 Grunwald, 1992, Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control, Investig. Ophthalmol. Vis. Sci., 33, 356 Grunwald, 1984, Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus, Ophthalmology, 91, 1447, 10.1016/S0161-6420(84)34124-0 Guariguata, 2014 Hadjadj, 2005, Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects, Diabetologia, 48, 1088, 10.1007/s00125-005-1747-x Hainsworth, 2002, Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus, Comp. Med., 52, 523 Hammer, 2009, Diabetic patients with retinopathy show increased retinal venous oxygen saturation, Graefes Arch. Clin. Exp. Ophthalmol., 247, 1025, 10.1007/s00417-009-1078-6 Hammes, 1995, Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats, Diabetologia, 38, 269, 10.1007/BF00400629 Hammes, 1997, Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine, Diabetologia, 40, 629, 10.1007/s001250050726 Hammes, 1996, Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization, Nat. Med., 2, 529, 10.1038/nm0596-529 Hammes, 2003, Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy, Nat. Med., 9, 294, 10.1038/nm834 Hammes, 1995, Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes, Mol. Med., 1, 527, 10.1007/BF03401589 Hammes, 2011, Diabetic retinopathy: targeting vasoregression, Diabetes, 60, 9, 10.2337/db10-0454 Hammes, 2002, Pericytes and the pathogenesis of diabetic retinopathy, Diabetes, 51, 3107, 10.2337/diabetes.51.10.3107 Hammes, 1991, Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy, Proc. Natl. Acad. Sci. U. S. A., 88, 11555, 10.1073/pnas.88.24.11555 Han, 2004, Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy, Arch. Ophthalmol., 122, 1809, 10.1001/archopht.122.12.1809 Hansen, 2015, Hypoxia-induced relaxation of porcine retinal arterioles in vitro depends on inducible NO synthase and EP receptor stimulation in the perivascular retina, Acta Ophthalmol. Hardarson, 2013, Retinal oximetry, Acta Ophthalmol., 91, 489, 10.1111/aos.12239 Hardarson, 2012, Retinal oxygen saturation is altered in diabetic retinopathy, Br. J. Ophthalmol., 96, 560, 10.1136/bjophthalmol-2011-300640 Harris, 1996, Hyperoxia improves contrast sensitivity in early diabetic retinopathy, Br. J. Ophthalmol., 80, 209, 10.1136/bjo.80.3.209 Harris Nwanyanwu, 2013, Predicting development of proliferative diabetic retinopathy, Diabetes Care, 36, 1562, 10.2337/dc12-0790 Harrison, 2011, Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes, Investig. Ophthalmol. Vis. Sci., 52, 772, 10.1167/iovs.10-5931 Hatchell, 1995, Diabetic retinopathy in a cat, Exp. Eye Res., 60, 591, 10.1016/S0014-4835(05)80074-0 Hayreh, 1980, Experimental occlusion of the central artery of the retina. IV: retinal tolerance time to acute ischaemia, Br. J. Ophthalmol., 64, 818, 10.1136/bjo.64.11.818 Hein, 2006, Dilation of retinal arterioles in response to lactate: role of nitric oxide, guanylyl cyclase, and ATP-sensitive potassium channels, Investig. Ophthalmol. Vis. Sci., 47, 693, 10.1167/iovs.05-1224 Heintz, 2010, Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden, Diabetologia, 53, 2147, 10.1007/s00125-010-1836-3 Heng, 2013, Diabetic retinopathy: pathogenesis, clinical grading, management and future developments, Diabet. Med., 30, 640, 10.1111/dme.12089 Henson, 1979, Dark adaptation in diabetes mellitus, Br. J. Ophthalmol., 63, 539, 10.1136/bjo.63.8.539 Hernandez, 2005, Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy, Diabet. Med., 22, 719, 10.1111/j.1464-5491.2005.01538.x Hernandez, 2013, Somatostatin replacement: a new strategy for treating diabetic retinopathy, Curr. Med. Chem., 20, 3251, 10.2174/09298673113209990024 Hidayat, 1985, Diabetic choroidopathy. Light and electron microscopic observations of seven cases, Ophthalmology, 92, 512, 10.1016/S0161-6420(85)34013-7 Hirsch, 2010, Beyond hemoglobin A1c–need for additional markers of risk for diabetic microvascular complications, JAMA, 303, 2291, 10.1001/jama.2010.785 Holman, 2008, Long-term follow-up after tight control of blood pressure in type 2 diabetes, N. Engl. J. Med., 359, 1565, 10.1056/NEJMoa0806359 Howell, 2013, Degeneration of retinal ganglion cells in diabetic dogs and mice: relationship to glycemic control and retinal capillary degeneration, Mol. Vis., 19, 1413 Hua, 2013, Imaging evidence of diabetic choroidopathy in vivo: angiographic pathoanatomy and choroidal-enhanced depth imaging, PLoS One, 8, e83494, 10.1371/journal.pone.0083494 Hubbard, 1999, Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study, Ophthalmology, 106, 2269, 10.1016/S0161-6420(99)90525-0 Huber, 2010, Novel rodent models for macular research, PLoS One, 5, e13403, 10.1371/journal.pone.0013403 Hughes, 2004, Advanced glycation endproduct modified basement membrane attenuates endothelin-1 induced [Ca2+]i signalling and contraction in retinal microvascular pericytes, Mol. Vis., 10, 996 Ikram, 2013, Retinal vascular caliber as a biomarker for diabetes microvascular complications, Diabetes Care, 36, 750, 10.2337/dc12-1554 Ishikawa, 1983, Occlusive thromboaortopathy (Takayasu's disease): cervical arterial stenoses, retinal arterial pressure, retinal microaneurysms and prognosis, Stroke, 14, 730, 10.1161/01.STR.14.5.730 Ismail-Beigi, 2010, Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial, Lancet, 376, 419, 10.1016/S0140-6736(10)60576-4 Ito, 2006, Myogenic tone and reactivity of rat ophthalmic artery in acute exposure to high glucose and in a type II diabetic model, Investig. Ophthalmol. Vis. Sci., 47, 683, 10.1167/iovs.05-1012 Iyer, 1998, Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha, Genes Dev., 12, 149, 10.1101/gad.12.2.149 Javitt, 1994, Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform, Diabetes Care, 17, 909, 10.2337/diacare.17.8.909 Jenkins, 2007, Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes, Diabet. Med., 24, 1345, 10.1111/j.1464-5491.2007.02281.x Jiang, 1996, Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1, J. Biol. Chem., 271, 17771, 10.1074/jbc.271.30.17771 Jiang, 2014, Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor alpha and suppressor of cytokine signaling 3, J. Biol. Chem., 289, 26395, 10.1074/jbc.M114.583880 Johnson, 2005, Ocular structure and function in an aged monkey with spontaneous diabetes mellitus, Exp. Eye Res., 80, 37, 10.1016/j.exer.2004.08.006 Jorgensen, 2014, The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy, Acta Ophthalmol., 92, 34, 10.1111/aos.12283 Josefsen, 1994, Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients, Clin. Exp. Immunol., 98, 489, 10.1111/j.1365-2249.1994.tb05517.x Joussen, 2004, A central role for inflammation in the pathogenesis of diabetic retinopathy, FASEB J., 18, 1450, 10.1096/fj.03-1476fje Kadiyala, 2012, Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC), J. Biol. Chem., 287, 25869, 10.1074/jbc.M112.375204 Kador, 1990, Prevention of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by aldose reductase inhibitors, Arch. Ophthalmol., 108, 1301, 10.1001/archopht.1990.01070110117035 Kador, 1994, Amelioration of diabetes-like retinal changes in galactose-fed dogs, Prev. Med., 23, 717, 10.1006/pmed.1994.1122 Kalfa, 1995, Altered proliferation of retinal microvascular cells on glycated matrix, Investig. Ophthalmol. Vis. Sci., 36, 2358 Kandarakis, 2014, Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases, Prog. Retin. Eye Res., 42, 85, 10.1016/j.preteyeres.2014.05.002 Kanguru, 2014, The burden of diabetes mellitus during pregnancy in low- and middle-income countries: a systematic review, Glob. Health Action, 7, 23987, 10.3402/gha.v7.23987 Kawagishi, 1999, Impaired endothelium-dependent vascular responses of retinal and intrarenal arteries in patients with type 2 diabetes, Arterioscler. Thromb. Vasc. Biol., 19, 2509, 10.1161/01.ATV.19.10.2509 Keech, 2007, Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial, Lancet, 370, 1687, 10.1016/S0140-6736(07)61607-9 Kern, 2008, Retinal ganglion cells in diabetes, J. Physiol., 586, 4401, 10.1113/jphysiol.2008.156695 Khan, 2006, Towards newer molecular targets for chronic diabetic complications, Curr. Vasc. Pharmacol., 4, 45, 10.2174/157016106775203081 Kim, 2014, High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: role in diabetic retinopathy, Arch. Biochem. Biophys., 560, 36, 10.1016/j.abb.2014.07.021 Kim, 2013, Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients, Investig. Ophthalmol. Vis. Sci., 54, 3378, 10.1167/iovs.12-11503 Kim, 2010, Nonsteroidal anti-inflammatory drugs in ophthalmology, Surv. Ophthalmol., 55, 108, 10.1016/j.survophthal.2009.07.005 Kim, 2004, Retinopathy in monkeys with spontaneous type 2 diabetes, Investig. Ophthalmol. Vis. Sci., 45, 4543, 10.1167/iovs.04-0519 Kim, 2012, Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments; 3-year results, Graefes Arch. Clin. Exp. Ophthalmol., 250, 679, 10.1007/s00417-011-1888-1 King, 2011, The influence of alloxan-induced diabetes on Muller cell contraction-promoting activities in vitreous, Investig. Ophthalmol. Vis. Sci., 52, 7485, 10.1167/iovs.11-7781 Kita, 2012, Identification of a VEGF-independent and Plasma Kallikrein-Kinin-dependent pathway of retinal vascular permeability in Diabetic Macular Edema, Investig. Ophthalmol. Vis. Sci., 2431, A526 Klaassen, 2013, Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions, Prog. Retin. Eye Res., 34, 19, 10.1016/j.preteyeres.2013.02.001 Klein, 1989, The Wisconsin epidemiological study of diabetic retinopathy: a review, Diabetes Metab. Rev., 5, 559, 10.1002/dmr.5610050703 Klein, 2007, Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy, Ophthalmology, 114, 1884, 10.1016/j.ophtha.2007.02.023 Klein, 2003, Retinal vascular abnormalities in persons with type 1 diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII, Ophthalmology, 110, 2118, 10.1016/S0161-6420(03)00863-7 Klein, 2004, The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy, Arch. Ophthalmol., 122, 76, 10.1001/archopht.122.1.76 Klein, 2008, The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes, Ophthalmology, 115, 1859, 10.1016/j.ophtha.2008.08.023 Klein, 2012, Changes in retinal vessel diameter and incidence and progression of diabetic retinopathy, Arch. Ophthalmol., 130, 749, 10.1001/archophthalmol.2011.2560 Klein, 2002, The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study, Ophthalmology, 109, 1225, 10.1016/S0161-6420(02)01074-6 Knott, 1999, A model system for the study of human retinal angiogenesis: activation of monocytes and endothelial cells and the association with the expression of the monocarboxylate transporter type 1 (MCT-1), Diabetologia, 42, 870, 10.1007/s001250051240 Kohner, 1993, The retinal blood flow in diabetes, Diabete Metab., 19, 401 Kohner, 1970, Fluorescein angiography of the fundus in diabetic retinopathy, Br. Med. Bull., 26, 166, 10.1093/oxfordjournals.bmb.a070770 Kohner, 1975, The retinal blood flow in diabetes, Diabetologia, 11, 27, 10.1007/BF00422814 Kohner, 1970, Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy, Am. J. Ophthalmol., 69, 403, 10.1016/0002-9394(70)92273-7 Kohner, 1995, Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy, Diabetes, 44, 603, 10.2337/diab.44.6.603 Kontturi, 2014, Encapsulated cells for long-term secretion of soluble VEGF receptor 1: material optimization and simulation of ocular drug response, Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik e.V Korobelnik, 2014, Intravitreal aflibercept for diabetic macular edema, Ophthalmology, 121, 2247, 10.1016/j.ophtha.2014.05.006 Kowalczuk, 2011, Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy, PLoS One, 6, e17462, 10.1371/journal.pone.0017462 Kowluru, 2015, Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy, Prog. Retin. Eye Res., 10.1016/j.preteyeres.2015.05.001 Kowluru, 2011, Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage, Diabetes, 60, 3023, 10.2337/db11-0816 Krugel, 2011, Involvement of oxidative stress and mitochondrial dysfunction in the osmotic swelling of retinal glial cells from diabetic rats, Exp. Eye Res., 92, 87, 10.1016/j.exer.2010.11.007 Kuiper, 2004, Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina, Br. J. Ophthalmol., 88, 1082, 10.1136/bjo.2003.032045 Kuo, 2014, Challenges in elucidating the genetics of diabetic retinopathy, JAMA Ophthalmol., 132, 96, 10.1001/jamaophthalmol.2013.5024 Kur, 2012, Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease, Prog. Retin. Eye Res., 31, 377, 10.1016/j.preteyeres.2012.04.004 Kurihara, 2012, Targeted deletion of Vegfa in adult mice induces vision loss, J. Clin. Investig., 122, 4213, 10.1172/JCI65157 Lai, 2013, Animal models of diabetic retinopathy: summary and comparison, J. Diabetes Res., 2013, 106594 Lambiase, 2009, Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma, Proc. Natl. Acad. Sci. U. S. A., 10.1073/pnas.0906678106 Lee, 2010, Ultrastructural features of retinal capillary basement membrane thickening in diabetic swine, Ultrastruct. Pathol., 34, 35, 10.3109/01913120903308583 Lewis, 2007, A qualitative study in the United Kingdom of factors influencing attendance by patients with diabetes at ophthalmic outpatient clinics, Ophthalmic Epidemiol., 14, 375, 10.1080/09286580701375195 Li, 2011, Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia, Mol. Vis., 17, 3156 Li, 2014, MiR-138 downregulates miRNA processing in HeLa cells by targeting RMND5A and decreasing Exportin-5 stability, Nucleic Acids Res., 42, 458, 10.1093/nar/gkt839 Li, 2012, Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 53, 5520, 10.1167/iovs.12-10010 Lieth, 1998, Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group, Diabetes, 47, 815, 10.2337/diabetes.47.5.815 Lim, 2012, Hyperglycemia induces apoptosis via CB1 activation through the decrease of FAAH 1 in retinal pigment epithelial cells, J. Cell Physiol., 227, 569, 10.1002/jcp.22756 Lim, 2008, Birth weight and retinal vascular changes, Hypertension, 51, e56, 10.1161/HYPERTENSIONAHA.108.112839 Linsenmeier, 1998, Retinal hypoxia in long-term diabetic cats, Investig. Ophthalmol. Vis. Sci., 39, 1647 Linsenmeier, 1982, Origin and sensitivity of the light peak in the intact cat eye, J. Physiol., 331, 653, 10.1113/jphysiol.1982.sp014396 Liu, 2013, Plasma kallikrein-kinin system and diabetic retinopathy, Biol. Chem., 394, 319, 10.1515/hsz-2012-0316 Liu, 2012, Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice, Mol. Med., 18, 1387, 10.2119/molmed.2012.00008 Lloyd, 1995, The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study, J. Diabetes Complicat., 9, 140, 10.1016/1056-8727(94)00039-Q Lockhart, 2014, Multimodal functional and anatomic imaging identifies preclinical microvascular abnormalities in type 1 diabetes mellitus, Am. J. Physiol. Heart Circ. Physiol., 307, H1729, 10.1152/ajpheart.00372.2014 Lois, 2013, Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy, Retina, 33, 13, 10.1097/IAE.0b013e3182657fff Looker, 2013, Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme, Diabetologia, 56, 1716, 10.1007/s00125-013-2928-7 Lopes-Virella, 2012, High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes, Diabetes Care, 35, 1333, 10.2337/dc11-2040 Lovett, 2015, Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics, Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharmazeutische Verfahrenstechnik e.V Lutty, 2013, Effects of diabetes on the eye, Investig. Ophthalmol. Vis. Sci., 54, ORSF81, 10.1167/iovs.13-12979 Lutty, 1997, Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid, Am. J. Pathol., 151, 707 Lyons, 2004, Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort, Investig. Ophthalmol. Vis. Sci., 45, 910, 10.1167/iovs.02-0648 Lyons, 1994, Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes, Diabetes, 43, 1090, 10.2337/diab.43.9.1090 Madsen-Bouterse, 2008, Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives, Rev. Endocr. Metab. Disord., 9, 315, 10.1007/s11154-008-9090-4 Maeda, 2014, Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products, Nutr. Res., 34, 807, 10.1016/j.nutres.2014.08.010 Mansour, 1990, Reduction of basement membrane thickening in diabetic cat retina by sulindac, Investig. Ophthalmol. Vis. Sci., 31, 457 Mason, 2012, High prevalence of sleep disordered breathing in patients with diabetic macular edema, Retina, 32, 1791, 10.1097/IAE.0b013e318259568b Massin, 2010, Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study, Diabetes Care, 33, 2399, 10.2337/dc10-0493 Mastropasqua, 2014, Role of microRNAs in the modulation of diabetic retinopathy, Prog. Retin. Eye Res., 43, 92, 10.1016/j.preteyeres.2014.07.003 McBain, 2011, Geographic atrophy in retinal angiomatous proliferation, Retina, 31, 1043, 10.1097/IAE.0b013e3181fe54c7 McGahon, 2007, Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscle, Circ. Res., 100, 703, 10.1161/01.RES.0000260182.36481.c9 McKnight, 2014, Genetic and epigenetic risk factors for diabetic kidney disease, Adv. Chronic Kidney Dis., 21, 287, 10.1053/j.ackd.2014.03.010 McVicar, 2011, Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy, Diabetes, 60, 2995, 10.2337/db11-0026 McVicar, 2015, Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice, Diabetologia, 10.1007/s00125-015-3523-x Medina, 2010, Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy, Investig. Ophthalmol. Vis. Sci., 51, 5906, 10.1167/iovs.09-4951 Medina, 2011, Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8, Mol. Med., 17, 1045, 10.2119/molmed.2011.00129 Metea, 2006, Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling, J. Neurosci., 26, 2862, 10.1523/JNEUROSCI.4048-05.2006 Metea, 2007, Signaling within the neurovascular unit in the retina, Exp. Physiol., 10.1113/expphysiol.2006.036376 Michaelides, 2010, A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2, Ophthalmology, 117, 10.1016/j.ophtha.2010.03.045 Miller, 2013, Vascular endothelial growth factor a in intraocular vascular disease, Ophthalmology, 120, 106, 10.1016/j.ophtha.2012.07.038 Minassian, 2012, Prevalence of diabetic macular oedema and related health and social care resource use in England, Br J Ophthalmol, 96, 345, 10.1136/bjo.2011.204040 Misfeldt, 2010, Novel cellular bouton structure activated by ATP in the vascular wall of porcine retinal arterioles, Investig. Ophthalmol. Vis. Sci., 51, 6681, 10.1167/iovs.10-5753 Misfeldt, 2010, Voltage-gated calcium channels are involved in the regulation of calcium oscillations in vascular smooth muscle cells from isolated porcine retinal arterioles, Exp. Eye Res., 91, 69, 10.1016/j.exer.2010.04.003 Mishra, 2011, Oxygen modulation of neurovascular coupling in the retina, Proc. Natl. Acad. Sci. U. S. A., 108, 17827, 10.1073/pnas.1110533108 Mishra, 2010, Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy, Glia, 58, 1996, 10.1002/glia.21068 Mishra, 2011, Aminoguanidine reverses the loss of functional hyperemia in a rat model of diabetic retinopathy, Front. Neuroenergetics, 3, 10 Mishra, 2014, Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 55, 7256, 10.1167/iovs.14-15193 Mitchell, 2011, The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema, Ophthalmology, 118, 615, 10.1016/j.ophtha.2011.01.031 Miyamoto, 1999, Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition, Proc. Natl. Acad. Sci. U.S.A, 96, 10836, 10.1073/pnas.96.19.10836 Mizutani, 1998, Muller cell changes in human diabetic retinopathy, Diabetes, 47, 445, 10.2337/diabetes.47.3.445 Mizutani, 1996, Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy, J.Clin. Investig., 97, 2883, 10.1172/JCI118746 Monaghan, 2015, Hyperglycemia and diabetes downregulate the functional expression of TRPV4 channels in retinal microvascular endothelium, PLoS One, 10, e0128359, 10.1371/journal.pone.0128359 Moore, 2003, The role of advanced glycation end products in retinal microvascular leukostasis, Investig. Ophthalmol. Vis. Sci., 44, 4457, 10.1167/iovs.02-1063 Mott, 1997, Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility, Kidney Int., 52, 1302, 10.1038/ki.1997.455 Muir, 2012, Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes, Investig. Ophthalmol. Vis. Sci., 53, 6488, 10.1167/iovs.12-9758 Murugeswari, 2014, Angiogenic potential of vitreous from Proliferative Diabetic Retinopathy and Eales' Disease patients, PLoS One, 9, e107551, 10.1371/journal.pone.0107551 Murugeswari, 2008, Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease, Retina, 28, 817, 10.1097/IAE.0b013e31816576d5 Narayanan, 2013, Arginase in retinopathy, Prog. Retin. Eye Res., 36, 260, 10.1016/j.preteyeres.2013.06.002 Nguyen, 2012, Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE, Ophthalmology, 119, 789, 10.1016/j.ophtha.2011.12.039 Nguyen, 2009, Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study, Ophthalmology, 116, 10.1016/j.ophtha.2009.04.023 Nguyen, 2010, Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study, Ophthalmology, 117, 2146, 10.1016/j.ophtha.2010.08.016 Nguyen, 2009, Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes, Investig. Ophthalmol. Vis. Sci., 50, 5609, 10.1167/iovs.09-3442 Nguyen, 2009, Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy, Diabetes Care, 32, 2075, 10.2337/dc09-0075 Nishijima, 2007, Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury, Am. J. Pathol., 171, 53, 10.2353/ajpath.2007.061237 Nishikawa, 2000, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, 404, 787, 10.1038/35008121 Noonan, 2013, An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes, Diabetes, 62, 3968, 10.2337/db13-0800 Omri, 2011, Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model, Am. J. Pathol., 179, 942, 10.1016/j.ajpath.2011.04.018 Omri, 2013, PKCzeta mediates breakdown of outer blood-retinal barriers in diabetic retinopathy, PLoS One, 8, e81600, 10.1371/journal.pone.0081600 Omri, 2010, The outer limiting membrane (OLM) revisited: clinical implications, Clin. Ophthalmol., 4, 183 Osborne, 2004, Retinal ischemia: mechanisms of damage and potential therapeutic strategies, Prog. Retin. Eye Res., 23, 91, 10.1016/j.preteyeres.2003.12.001 Padayatti, 2001, High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells, Curr. Eye Res., 23, 106, 10.1076/ceyr.23.2.106.5472 Pannicke, 2006, Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina, Diabetes, 55, 633, 10.2337/diabetes.55.03.06.db05-1349 Park, 2014, Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature, Circulation, 129, 359, 10.1161/CIRCULATIONAHA.113.003000 Patel, 1994, Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemia, Clin.Sci. (Lond.), 86, 689, 10.1042/cs0860689 Pemp, 2009, Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes, Investig. Ophthalmol. Vis. Sci., 50, 4029, 10.1167/iovs.08-3260 Perrone, 2014, Epigenetic modifications and potential new treatment targets in diabetic retinopathy, J. Ophthalmol., 2014, 789120 Pfister, 2008, Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy, Diabetes, 57, 2495, 10.2337/db08-0325 Pfister, 2013, Pericytes in the eye, Pflugers Arch., 465, 789, 10.1007/s00424-013-1272-6 Qing, 2014, Serum miRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy, Cell. Physiol. Biochem., 34, 1733, 10.1159/000366374 Querques, 2012, Enhanced depth imaging optical coherence tomography in type 2 diabetes, Investig. Ophthalmol. Vis. Sci., 53, 6017, 10.1167/iovs.12-9692 Ragusa, 2013, MicroRNAs in vitreus humor from patients with ocular diseases, Mol. Vis., 19, 430 Rand, 1985, Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10, Investig. Ophthalmol. Vis. Sci., 26, 983 Rangasamy, 2014, Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy, PLoS One, 9, e108508, 10.1371/journal.pone.0108508 Rassam, 1995, The effect of experimental hypertension on retinal vascular autoregulation in humans: a mechanism for the progression of diabetic retinopathy, Exp. Physiol., 80, 53, 10.1113/expphysiol.1995.sp003834 Rathmann, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 2568, 10.2337/diacare.27.10.2568 Rauck, 2014, Biocompatible reverse thermal gel sustains the release of intravitreal bevacizumab in vivo, Investig. Ophthalmol. Vis. Sci., 55, 469, 10.1167/iovs.13-13120 Reddy, 2015, Epigenetic mechanisms in diabetic complications and metabolic memory, Diabetologia, 58, 443, 10.1007/s00125-014-3462-y Regnier, 2014, Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis, PLoS One, 9, e102309, 10.1371/journal.pone.0102309 Reiter, 2003, Functions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathy, Prog. Retin. Eye Res., 22, 545, 10.1016/S1350-9462(03)00035-1 Resnikoff, 2004, Global data on visual impairment in the year 2002, Bull. World Health Organ, 82, 844 Rhatigan, 1999, Blindness in patients with diabetes who have been screened for eye disease, Eye (Lond., Engl.), 13, 166, 10.1038/eye.1999.44 Robinson, 2012, Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals, Dis. Models Mech., 5, 444, 10.1242/dmm.009597 Romero-Aroca, 2010, Prospective comparison of two methods of screening for diabetic retinopathy by nonmydriatic fundus camera, Clin. Ophthalmol., 4, 1481, 10.2147/OPTH.S14521 Rosales, 2014, S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 55, 2921, 10.1167/iovs.13-13762 Rosales, 2014, Endocytosis of tight junctions caveolin nitrosylation dependent is improved by cocoa via opioid receptor on RPE cells in diabetic conditions, Investig. Ophthalmol. Vis. Sci., 55, 6090, 10.1167/iovs.14-14234 Roy, 2011, Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus, Arch. Ophthalmol., 129, 8, 10.1001/archophthalmol.2010.340 Roy, 2010, Vascular basement membrane thickening in diabetic retinopathy, Curr. Eye Res., 35, 1045, 10.3109/02713683.2010.514659 Roy, 1994, Increased expression of basement membrane collagen in human diabetic retinopathy, J.Clin. Investig., 93, 438, 10.1172/JCI116979 Roy, 2003, Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats, Diabetes, 52, 1229, 10.2337/diabetes.52.5.1229 Roy, 2010, Aging increases retinal vascular lesions characteristic of early diabetic retinopathy, Biogerontology, 11, 447, 10.1007/s10522-010-9263-x Rubin, 2015, Precision medicine: the future or simply politics?, JAMA, 313, 1089, 10.1001/jama.2015.0957 Rungger-Brandle, 2000, Glial reactivity, an early feature of diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 41, 1971 Runkle, 2011, The blood-retinal barrier: structure and functional significance, Methods Mol. Biol., 686, 133, 10.1007/978-1-60761-938-3_5 Russo, 2015, Comparison of smartphone ophthalmoscopy with slit-lamp biomicroscopy for grading diabetic retinopathy, Am. J. Ophthalmol., 159, 10.1016/j.ajo.2014.11.008 Russo, 2015, A novel device to exploit the smartphone camera for fundus photography, J. Ophthalmol., 2015, 823139 Sacks, 2014, Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries, Circulation, 129, 999, 10.1161/CIRCULATIONAHA.113.002529 Sahoo, 2015, Topical non-steroidal anti-inflammatory agents for diabetic cystoid macular oedema, Cochrane Database Syst. Rev., 2, CD010009 Saint-Geniez, 2004, Development and pathology of the hyaloid, choroidal and retinal vasculature, Int. J. Dev. Biol., 48, 1045, 10.1387/ijdb.041895ms Saint-Geniez, 2008, Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors, PLoS One, 3, e3554, 10.1371/journal.pone.0003554 Samuels, 2015, Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes, J. Neurophysiol., 113, 1085, 10.1152/jn.00761.2014 Samuels, 2012, Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease, Vis. Neurosci., 29, 267, 10.1017/S0952523812000326 Samuels, 2010, Light-evoked responses of the retinal pigment epithelium: changes accompanying photoreceptor loss in the mouse, J. Neurophysiol., 104, 391, 10.1152/jn.00088.2010 Sandholm, 2012, New susceptibility loci associated with kidney disease in type 1 diabetes, PLoS Genet., 8, e1002921, 10.1371/journal.pgen.1002921 Sang, 2008, Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?, Diabetologia, 51, 1570, 10.1007/s00125-008-1078-9 Scanlon, 2008, Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening, Br. J. Ophthalmol., 92, 775, 10.1136/bjo.2007.128561 Schmetterer, 1999, Ocular blood flow and associated functional deviations in diabetic retinopathy, Diabetologia, 42, 387, 10.1007/s001250051171 Schram, 2003, Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study, Diabetes Care, 26, 2165, 10.2337/diacare.26.7.2165 Scott, 2014, Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR), Exp. Eye Res., 120, 55, 10.1016/j.exer.2013.12.020 Scott, 2014, Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in patients with severe nonproliferative or non-high-risk proliferative diabetic retinopathy: a randomized clinical trial, JAMA Ophthalmol., 132, 535, 10.1001/jamaophthalmol.2014.93 Semenza, 2000, HIF-1 and human disease: one highly involved factor, Genes Dev., 14, 1983, 10.1101/gad.14.16.1983 Semeraro, 2015, Efficacy and vitreous levels of topical NSAIDs, Expert Opin. Drug Deliv., 1 Seok, 2013, Genomic responses in mouse models poorly mimic human inflammatory diseases, Proc. Natl. Acad. Sci. U. S. A., 110, 3507, 10.1073/pnas.1222878110 Sfikakis, 2010, Infliximab for diabetic macular edema refractory to laser photocoagulation: a randomized, double-blind, placebo-controlled, crossover, 32-week study, Diabetes Care, 33, 1523, 10.2337/dc09-2372 Shen, 2012, Conditional Mullercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model, J. Neurosci., 32, 15715, 10.1523/JNEUROSCI.2841-12.2012 Shi, 2015, Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis, Br. J. Ophthalmol., 10.1136/bjophthalmol-2014-305631 Shiragami, 2002, Risk factors for diabetic choroidopathy in patients with diabetic retinopathy, Graefes Arch. Clin. Exp. Ophthalmol., 240, 436, 10.1007/s00417-002-0451-5 Silva, 2010, Effect of systemic medications on onset and progression of diabetic retinopathy, Nat. Rev. Endocrinol., 6, 494, 10.1038/nrendo.2010.122 Silva, 2013, Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity, Ophthalmology, 120, 2587, 10.1016/j.ophtha.2013.05.004 Silva, 2014, Potential efficiency benefits of nonmydriatic ultrawide field retinal imaging in an ocular telehealth diabetic retinopathy program, Diabetes Care, 37, 50, 10.2337/dc13-1292 Simo-Servat, 2012, Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy, Mediat. Inflamm., 2012, 872978, 10.1155/2012/872978 Simo, 2013, New insights in the pathogenesis and treatment of diabetic retinopathy, Curr. Med. Chem., 20, 3187, 10.2174/0929867311320260001 Simo, 2009, Advances in the medical treatment of diabetic retinopathy, Diabetes Care, 32, 1556, 10.2337/dc09-0565 Simo, 2012, Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate, Rev. Recent Clin. Trials, 7, 71, 10.2174/157488712799363299 Simo, 2014, Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives, Trends Endocrinol. Metab., 25, 23, 10.1016/j.tem.2013.09.005 Simo, 2014, Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy, Diabetes Care, 37, 893, 10.2337/dc13-2002 Simo, 2010, The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier–implications for the pathogenesis of diabetic retinopathy, J. Biomed. Biotechnol., 2010, 190724 Sinclair, 1982, Retinal vascular autoregulation in diabetes mellitus, Ophthalmology, 89, 748, 10.1016/S0161-6420(82)34720-X Sivaprasad, 2012, Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK), PLoS One, 7, e39608, 10.1371/journal.pone.0039608 Skovborg, 1969, Diameters of the retinal vessels in diabetic and normal subjects, Diabetes, 18, 292, 10.2337/diab.18.5.292 Smith, 1994, Oxygen-induced retinopathy in the mouse, Investig. Ophthalmol. Vis. Sci., 35, 101 Sone, 1997, Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes, Diabetologia, 40, 726, 10.1007/s001250050740 Spranger, 2001, Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?, Horm. Metab. Res., 33, 312, 10.1055/s-2001-15283 Stefansson, 2000, Screening and prevention of diabetic blindness, Acta Ophthalmol. Scand., 78, 374, 10.1034/j.1600-0420.2000.078004374.x Stirban, 2013, A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes, Diabet. Med., 30, 1204, 10.1111/dme.12240 Stitt, 2002, The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes, Diabetes, 51, 2826, 10.2337/diabetes.51.9.2826 Stitt, 1994, Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments, Br. J. Ophthalmol., 78, 133, 10.1136/bjo.78.2.133 Stitt, 2002, The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes, Diabetes, 51, 2826, 10.2337/diabetes.51.9.2826 Stitt, 1995, Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients, Br. J. Ophthalmol., 79, 362, 10.1136/bjo.79.4.362 Stitt, 2004, Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor, Diabetologia, 47, 1735, 10.1007/s00125-004-1523-3 Stitt, 1997, Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats, Am. J. Pathol., 150, 523 Stitt, 2013, Advances in our understanding of diabetic retinopathy, Clin. Sci. (Lond.), 125, 1, 10.1042/CS20120588 Stitt, 2005, Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3, Diabetes, 54, 785, 10.2337/diabetes.54.3.785 Stitt, 2011, Vascular stem cells and ischaemic retinopathies, Prog. Retin Eye Res., 30, 149, 10.1016/j.preteyeres.2011.02.001 Stratton, 2013, A simple risk stratification for time to development of sight-threatening diabetic retinopathy, Diabetes Care, 36, 580, 10.2337/dc12-0625 Sugimoto, 2013, Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage, Am. J. Pathol., 183, 987, 10.1016/j.ajpath.2013.05.017 Takeuchi, 2010, Involvement of TAGE-RAGE system in the pathogenesis of diabetic retinopathy, J. Ophthalmol., 2010, 170393 Talahalli, 2012, Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes, J. Leukoc. Biol. Tang, 2011, Inflammation in diabetic retinopathy, Prog. Retin. Eye Res., 30, 343, 10.1016/j.preteyeres.2011.05.002 Tarallo, 2012, Human pericyte-endothelial cell interactions in co-culture models mimicking the diabetic retinal microvascular environment, Acta Diabetol., 10.1007/s00592-012-0390-5 Taylor-Phillips, 2015, Extending the diabetic retinopathy screening interval beyond 1 year: systematic review, Br. J. Ophthalmol. 2003, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study, JAMA, 290, 2159, 10.1001/jama.290.16.2159 Thomas, 2015, Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service, Br. J. Ophthalmol., 99, 64, 10.1136/bjophthalmol-2013-304017 Tolentino, 1996, Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate, Ophthalmology, 103, 1820, 10.1016/S0161-6420(96)30420-X Trick, 2006, Early supernormal retinal oxygenation response in patients with diabetes, Investig. Ophthalmol. Vis. Sci., 47, 1612, 10.1167/iovs.05-0833 Trick, 2008, MRI retinovascular studies in humans: research in patients with diabetes, NMR Biomed., 21, 1003, 10.1002/nbm.1314 Trick, 2005, Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results, Exp. Eye Res., 81, 97, 10.1016/j.exer.2005.01.015 Trudeau, 2011, Fenofibric acid reduces fibronectin and collagen type IV overexpression in human retinal pigment epithelial cells grown in conditions mimicking the diabetic milieu: functional implications in retinal permeability, Investig. Ophthalmol. Vis. Sci., 52, 6348, 10.1167/iovs.11-7282 Tsai, 2011, Differential association of retinal arteriolar and venular caliber with diabetes and retinopathy, Diabetes Res. Clin. Pract., 94, 291, 10.1016/j.diabres.2011.07.032 Tso, 1988, Microangiopathic retinopathy in experimental diabetic monkeys, Trans. Am. Ophthalmol. Soc., 86, 389 Tzekov, 1999, The electroretinogram in diabetic retinopathy, Surv. Ophthalmol., 44, 53, 10.1016/S0039-6257(99)00063-6 UKPDS, 1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group, Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8 UKPDS, 1998, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group, BMJ, 317, 703, 10.1136/bmj.317.7160.703 Unsal, 2014, Choroidal thickness in patients with diabetic retinopathy, Clin. Ophthalmol., 8, 637, 10.2147/OPTH.S59395 Vacca, 2014, AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers, Glia, 62, 468, 10.1002/glia.22617 Valle, 2013, Reduction of circulating neutrophils precedes and accompanies type 1 diabetes, Diabetes, 62, 2072, 10.2337/db12-1345 Valverde, 2013, Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy, Mol. Vis., 19, 47 van Dieren, 2011, External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes, Diabetologia, 54, 264, 10.1007/s00125-010-1960-0 van Dijk, 2009, Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 50, 3404, 10.1167/iovs.08-3143 van Dijk, 2010, Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes, Investig. Ophthalmol. Vis. Sci., 51, 3660, 10.1167/iovs.09-5041 van Dijk, 2012, Early neurodegeneration in the retina of type 2 diabetic patients, Investig. Ophthalmol. Vis. Sci., 53, 2715, 10.1167/iovs.11-8997 van Dijk, 2011, Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy, Vis. Res., 51, 224, 10.1016/j.visres.2010.08.024 van Leiden, 2002, Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study, Diabetes Care, 25, 1320, 10.2337/diacare.25.8.1320 Vergouwe, 2010, Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule, Diabetologia, 53, 254, 10.1007/s00125-009-1585-3 Vessey, 2011, Characterization of retinal function and glial cell response in a mouse model of oxygen-induced retinopathy, J. Comp. Neurol., 519, 506, 10.1002/cne.22530 Villarroel, 2009, Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells, Exp. Eye Res., 89, 913, 10.1016/j.exer.2009.07.017 Villeneuve, 2010, The role of epigenetics in the pathology of diabetic complications, Am. J. Physiol. Ren. Physiol., 299, F14, 10.1152/ajprenal.00200.2010 Virgili, 2014, Anti-vascular endothelial growth factor for diabetic macular oedema, Cochrane Database Syst. Rev., 10, CD007419 Vujosevic, 2012, Macular and peripapillary choroidal thickness in diabetic patients, Retina, 32, 1781, 10.1097/IAE.0b013e31825db73d Wagener, 1934, Retinitis in diabetes, N. Engl. J. Med., 211, 1131, 10.1056/NEJM193412202112502 Wang, 2007, AGEs mediated expression and secretion of TNF alpha in rat retinal microglia, Exp. Eye Res., 84, 905, 10.1016/j.exer.2007.01.011 Wangsa-Wirawan, 2003, Retinal oxygen: fundamental and clinical aspects, Arch. Ophthalmol., 121, 547, 10.1001/archopht.121.4.547 Weiland, 2012, Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases, RNA Biol., 9, 850, 10.4161/rna.20378 Weinberger, 1995, Non-retinovascular leakage in diabetic maculopathy, Br. J. Ophthalmol., 79, 728, 10.1136/bjo.79.8.728 Weinberger, 1998, Indocyanine green angiographic findings in nonproliferative diabetic retinopathy, Am. J. Ophthalmol., 126, 238, 10.1016/S0002-9394(98)00148-2 Wessel, 2012, Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy, Retina, 32, 785, 10.1097/IAE.0b013e3182278b64 White, 2008, Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial, Arch. Ophthalmol., 126, 1707, 10.1001/archopht.126.12.1707 White, 2010, Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents, Diabetes, 59, 1244, 10.2337/db09-1216 Williams, 2012, Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy, Diabetes, 61, 2187, 10.2337/db11-0751 Wong, 2011, Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape, Arch. Ophthalmol., 129, 95, 10.1001/archophthalmol.2010.347 Woo, 2011, Elevated systemic neutrophil count in diabetic retinopathy and diabetes: a hospital-based cross-sectional study of 30,793 Korean subjects, Investig. Ophthalmol. Vis. Sci., 52, 7697, 10.1167/iovs.11-7784 Wu, 2013, Classification of diabetic retinopathy and diabetic macular edema, World J. Diabetes, 4, 290, 10.4239/wjd.v4.i6.290 Wu, 2012, Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Muller cells, Investig. Ophthalmol. Vis. Sci., 53, 4595, 10.1167/iovs.12-9910 Xie, 2014, Interleukin-4 and melatonin ameliorate high glucose and interleukin-1beta stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells, Mol. Vis., 20, 921 Xu, 2009, Para-inflammation in the aging retina, Prog. Retin. Eye Res., 28, 348, 10.1016/j.preteyeres.2009.06.001 Xu, 2011, Significance of outer blood-retina barrier breakdown in diabetes and ischemia, Investig. Ophthalmol. Vis. Sci., 52, 2160, 10.1167/iovs.10-6518 Yamanishi, 2006, Extracellular lactate as a dynamic vasoactive signal in the rat retinal microvasculature, Am. J. Physiol. Heart Circ. Physiol., 290, H925, 10.1152/ajpheart.01012.2005 Yan, 2014, Aberrant expression of long noncoding RNAs in early diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 55, 941, 10.1167/iovs.13-13221 Yan, 2015, lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA, Circ. Res., 116, 1143, 10.1161/CIRCRESAHA.116.305510 Yau, 2012, Global prevalence and major risk factors of diabetic retinopathy, Diabetes Care, 35, 556, 10.2337/dc11-1909 Yokouchi, 2013, Angiopoietin-like protein 4 (ANGPTL4) is induced by high glucose in retinal pigment epithelial cells and exhibits potent angiogenic activity on retinal endothelial cells, Acta Ophthalmol., 91, e289, 10.1111/aos.12097 Yong, 2010, Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Muller glia dysfunction and death in diabetic retinopathy, Mol. Vis., 16, 2524 Yu, 2007, Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat, Investig. Ophthalmol. Vis. Sci., 48, 2290, 10.1167/iovs.06-1197 Yu, 2013, Modified lipoproteins in diabetic retinopathy: a local action in the retina, J. Clin. Exp. Ophthalmol., 4 Yu, 2003, Physiological and pathological implications of semicarbazide-sensitive amine oxidase, Biochim. Biophys. Acta, 1647, 193, 10.1016/S1570-9639(03)00101-8 Zager, 1988, Reduction of cellular energy requirements. Screening for agents that may protect against CNS ischemia, J. Neurosurg., 69, 568, 10.3171/jns.1988.69.4.0568 Zeng, 2008, Microglial activation in human diabetic retinopathy, Arch. Ophthalmol., 126, 227, 10.1001/archophthalmol.2007.65 Zeng, 2000, Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats, Vis. Neurosci., 17, 463, 10.1017/S0952523800173122 Zhang, 2015, The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding, Prog. Retin. Eye Res., 45, 111, 10.1016/j.preteyeres.2014.12.001 Zhao, 2011, Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina, Investig. Ophthalmol. Vis. Sci., 52, 6340, 10.1167/iovs.11-7675 Zhao, 2010, The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Muller glial cells, FASEB J., 24, 3405, 10.1096/fj.09-154344 Zheng, 2012, The worldwide epidemic of diabetic retinopathy, Indian J. Ophthalmol., 60, 428, 10.4103/0301-4738.100542 Ziegler, 2012, Comment on: Fraser et al. the effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial, Diabetes Care, 35, 1095, 10.2337/dc12-0817 Zong, 2010, Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE), Diabetologia, 53, 2656, 10.1007/s00125-010-1900-z Zong, 2011, AGEs, RAGE, and diabetic retinopathy, Curr. Diab Rep., 11, 244, 10.1007/s11892-011-0198-7